Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Agenda 2021

Schedule at a Glance
as of April 12, 2021 - Download here


Monday, 26 April 2021
10:00 - 10:15 amWelcome & Opening Remarks
Dr Christian Stein & Esther Lange, Ascenion
10:15 - 10:20 am

Welcome Speech
Hubert Aiwanger, MdL
Bavarian State Minister of Economic Affairs, Regional Development and Energy

10:20 - 11:00 am

Presentation Stream I: Immunology
Chair: Dr Jürgen Walkenhorst, PROvendis


Startup Pitches
Part 1:

Alterras Therapeutics
AVVie GmbH
iRASP Therapeutics

MyoPax Berlin
Klavant GmbH
LifeTaq-Analytics GmbH
Metaron Diagnostics

M1Transdermal targeted delivery for immunomodulation
Dr Robert Wawrzinek, Max-Planck Institute of Colloids and Interfaces
M5Cholesterol-synthesis intermediates for treatment of demyelinating disorders
Dr Gesine Saher, Max Planck Institute of Experimental Medicine
N6siRNA targeting variant C1858T of gene ptpn22
Dr Alessandra Fierabracci, IRCCS - Bambino Gesù Children's Hospital
W2NovoArc - we replace injections with pills!
Prof. Oliver Spadiut, Vienna University of Technology
11:00 - 11:30 amQ&A Presentation Stream I 
11:30 - 11:40 amSponsor Talk/Video - AbbVie  
11:40 am - 12:00 pmMeet-The-PartnersSponsor Room - AbbVie 
          - 12:40 pm 
12:00 - 01:30 pmMatchmaking Lunch
01:30 - 02:20 pm

Presentation Stream II: Infection
Chair: Dr Thomas Hesterkamp, DZIF - German Center for Infection Research

I3Small binding proteins mimicking epitopes of broadly neutralizing antibodies as antigens for development of a vaccine against HIV-1 infection
Dr Milan Raška, Palacky University Olomouc
D2Urea motif containing compounds and derivatives thereof as antibacterial drugs - aBACTER
Robert Macsics, Technical University of Munich - Project aBACTER
I1Lipophosphonoxins - Novel broad-sprectrum antimicrobial agents
Dr Dominik Rejman, Institute of Organic Chemistry and Biochemistry (IOCB)
N14Novel compounds active against multidrug-resistant highly-prioritized superbugs
Prof. Rosario Musumeci, University of Milano-Bicocca
N7TMEK - the quantative rapid diagnostic test for Malaria
Dr Jonathan Barsotti, Politecnico di Milano
02:00 pm  

Startup Pitches
Part 2:

PolyGlyco Biotech (GbR)
wellabe GmbH

MitOx Therapeutics
NovoArc GmbH
Penton Biotech

BioM inQlab - Virtual Startup Incubator for the Medicine of the Future
02:20 - 02:50 pmQ&A Presentation Stream II 
02:50 - 03:00 pmSponsor Talk/Video - Pfizer 
03:00 pm Sponsor Room - Pfizer
04:00 pm  
04:00 pmClosing Day One


Tuesday, 27 April 2021
10:00 - 10:05 amWelcome Day Two
10:05 - 11:05 am

Presentation Stream III: Gene Therapy, Gene Editing & Nucleic Acids
Chair: Dr Stefanie Possekel, Ascenion GmbH


Investor Introduction

A2CRISPR-Switch: Precisely regulated sgRNA for tight, safe and efficient genome editing
Dr Torsten Stachelhaus, Ascenion GmbH
C2CaPRiCoRN: CRISPR/Cas9 ribonucleoprotein containing retroviral nanoparticles for safe gene therapies
Dr Florian Gatzke, Goethe University Hospital Frankfurt am Main
A1Novel gene therapy approach for cardiovascular diseases
Prof. Christian Kupatt, MRI, Technical University of Munich
A5DMD gene therapy approach
Prof. Wolfgang Wurst, Helmholtz Zentrum München
O2Chemical synthesis strategy for increasing the stability and biocompatibility of chemically-synthesised therapeutic oligonucleotides
Prof. Tom Brown, University of Oxford
11:05 - 11:35 amQ&A Presentation Stream III 

How to Commercialize Biomarker Based Inventions?

Join the Discussion with the Baltic Sea Region Partners

11:35 - 11:45 amSponsor Talk/Video 3 

Speed Dating
Part 1

Closed Session

11:45 am - 12:45 pm Sponsor Room 3
12:00 - 01:30 pmLunch & Networking 
01:30 - 02:10 pm

Presentation Stream IV: Oncology
Chair: Dr Laura Spinardi, Netval

I7CasInvent Pharma - Developing highly potent and selective inhibitors of CK1 kinases for the treatment of leukemias, lymphomas and solid tumors
David Stíbal, Masaryk University
W7Targeting STAT5 oligomerization in leukemia
Dr Anna Orlova, University of Veterinary Medicine Vienna
M4Selective CDK12 inhibitors & synthetic lethality
Thomas Kirmeier, Lead Discovery Center GmbH
E3Method for screening of compounds to modulate glycolysis in cancer cells
Dr Ina Huppertz, European Molecular Biology Laboratory (EMBL)
02:10 - 02:40 pmQ&A Presentation Stream IV

Speed Dating
Part 2

Closed Session

02:40 - 02:50 pmSponsor Talk/Video - Johnson & Johnson Innovation  
02:50 - 03:50 pm Sponsor Room - Johnson & Johnson Innovation 
04:00 pm   
04:00 pmClosing Day Two


Wednesday, 28 April 2021
10:00 - 10:05 amWelcome Day Three
10:05 - 11:15 am

Presentation Stream V: Neurology & Pain
Chair: Dr Juliane Proft, IOCB Tech



O3Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
Prof. George Tofaris, University of Oxford
B2Better together – Novel dual-acting and disease-modifying approach to combat Alzheimer’s
Matthias Scheiner, Julius-Maximilians-Universität of Würzburg
A7Novel treatment of dementia-associated tauopathies
Prof. Evgeni Ponimaskin, MHH - Hannover Medical School
A3Targeting NMDAR encephalitis with Chimeric AutoAntibody Receptor T cell therapy (CAAR-T)
Dr S. Momsen Reincke, DZNE - German Center for Neurodegenerative Diseases
N4Muscular miRNAs in SMA: use as biomarkers and therapeutics
Dr Emanuela Abiusi, Università Cattolica del Sacro Cuore
A4Novel small molecule inhibitors of STOML3 for treatment of diabetic neuropathy
Prof. Gary Lewin, Max Delbrück Center for Molecular Medicine
11:00 am   

Patenting Computer-Implemented Innovations under the EPC

Dr Andreas Werner, European Patent Office

11:15 - 12:15 amQ&A Presentation Stream V 
12:15 - 12:25 amSponsor Talk/Video - Boehringer Ingelheim 


01:00 pm   
12:25 am - 01:25 pm Sponsor Room - Boehringer Ingelheim  
01:00 - 02:00 pmLunch & Networking
02:00 - 03:00 pm

Presentation Stream VI: Metabolism & Fertility
Chair: Dr Malgorzata Barczyk, VIS

C3Bispecific small molecule for treatment of metabolic syndrome, chronic kidney disease, NAFLD, NASH
Dr Daniel Merk, Goethe University Frankfurt am Main
N3Novel small-molecules acting as agonists of GLP-1 receptor: innovative treatment for diabesity and liver diseases
Prof. Mauro Pineschi, University of Pisa
P6Adenosine/A2B Receptor Agonists for the Treatment of Age-Related Muscle Loss
Prof. Alexander Pfeifer, University of Bonn
V2A corrective therapy for acute intermittent porphyria
Dr Juha Kallio, University of Bergen
N8Kit for in vitro diagnosis of infertility or abortion risk for women
Prof. Maria Matteo, University of Foggia
P1Novel markers for proof of sperm quality – easy and standardized detection of male infertility problems
Dr Melanie von Brandenstein, University Hospital of Cologne
03:00 - 03:30 pmQ&A Presentation Stream VIStartup Award Ceremony 
03:30 - 03:40 pmSponsor Talk/Video - Grünecker Patent Attorneys and Attorneys-At-Law   
03:40 - 04:40 pm Sponsor Room - Grünecker  
04:40 pmClosing BioVaria 2021Networking